InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
T+90 hit rate
57%
T+90 mean return
+10.2%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Okey Stephanie, Director. Director active across 3 companies, notably Crinetics Pharmaceuticals, Inc.. In total, 21 disclosures have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €680k. Activity tracked since 13 August 2021. The latest transaction was filed on 3 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations21 total
5,925 sharesCommon StockSEC:0001628280-26-044708:0
6,292 sharesCommon StockSEC:0001628280-26-044419:0
608 sharesCommon StockSEC:0001628280-26-044419:1
3,000 shares@ US$39.670.0023% mcap50.0% of flowCommon StockSEC:0001628280-26-014775
3,000 shares@ US$39.670.0023% mcap50.0% of flowCommon StockSEC:0001628280-26-014775:0
5,000 shares@ US$54.0052.0% of flowCommon StockSEC:0001415889-25-008235:0
4,000 shares0Common StockSEC:0001415889-25-001024:0
12,635 sharesCommon StockSEC:0000950170-24-137726:0
4,663 shares0Common StockSEC:0001596783-24-000109:0
3,400 shares0Common StockSEC:0000950170-24-071928:0
17,500 shares@ US$18.2959.3% of flowCommon StockSEC:0001209191-24-005184:0
4,000 shares0Common StockSEC:0001415889-24-004116:0
6,993 shares0Common StockSEC:0001596783-23-000139:0
979 shares0Common StockSEC:0001596783-23-000123:0
6,000 shares0Common StockSEC:0001209191-23-038822:0
4,000 shares0Common StockSEC:0001415889-23-000667:0
2,296 shares@ US$51.62124.4% of flowCommon StockSEC:0001415889-22-008493:0
3,200 shares0Common StockSEC:0001179110-22-000388:0
3,200 shares0Common StockSEC:0001179110-22-000388
1,650 shares@ US$40.0570.0009% mcap50.0% of flowCommon StockSEC:0001179110-21-008233:0
1,650 shares@ US$40.05711.8% of flowCommon StockSEC:0001179110-21-008233
21 of 21 declarations
About Okey Stephanie
Stephanie Okey is a Director at Crinetics Pharmaceuticals, Inc. and PTC Therapeutics, Inc. She participates in the governance of the companies and in strategic decision-making. Okey brings valuable expertise in the pharmaceutical sector.
